Renee A. Reijo Pera, Ph.D.
Academic Appointments
- Professor, Obstetrics & Gynecology - Obstetrics & Gynecology - Institutes
- Member, Child Health Research Institute
- Member, Bio-X
- Member, Stanford Cancer Institute
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 725-3803 Tel (650) 723-6716Administrative Contact Peggy Cuadro Administrative Assistant Email Tel Work 650-723-5569
Professional Overview
Administrative Appointments
- Director, Interdepartmental Graduate Program in Stem Cell Biology and Regenerative Medicine (2011 - present)
- Director, Center for Reproductive and Stem Cell Biology (2010 - present)
- Director, Center for Human Pluripotent Stem Cell Research and Education (2007 - present)
Honors and Awards
- George D Smith Professor of Stem Cell Biology and Regenerative Medicine, Stanford University (2012-present)
- Top Ten Medical Breakthrough of the Year, Time Magazine (2010)
- Founder's Award, Australian Society for Reproductive Biology (2010)
- Honorary Doctorate, University of Wisconsin Superior (2009)
- Bruce Stewart Award, American Society for Reproductive Medicine (ASRM) (2007)
- Twenty Influential Women Leaders in the USA, Newsweek, Inc (09-2006)
Professional Education
| Fellow: | Whitehead Institute, Human Genetics (1997) |
| Ph.D.: | Cornell University, Molecular and Cell Biology (1993) |
| M.S.: | Kansas State University, Entomology (1987) |
| B.S.: | University of Wisconsin, Biology (1983) |
Postdoctoral Advisees
HyoJin Chiang, Jun Cui, Fang Fang, Jinnuo Han, Smruti Phadnis, Cyril Ramathal, Sonya Schuh-Huerta, Mark Wossidlo, Ninuo Xia, Pengbo Zhang
Graduate & Fellowship Program Affiliations
Community and International Work
- International Stem Cell Initiative, International
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Our laboratory is focused on three inter-related areas of research: 1) Understanding early decisions in human development, 2) examining genetic and epigenetic requirements for formation of the germ cells that give rise to each generation, and 3) understanding the basis for sporadic diseases such as Parkinson's Disease that may be linked to complex genetic and/or epigenetic and developmental errors.
Human embryo development begins with the fusion of egg and sperm, a remodeling of the maternal and paternal pronuclei and a series of cleavage divisions. Subsequently, on Day 3, the embryonic genome is activated and the stage is set for a series of cell fate decisions that lead to formation of the distinct tissues of the blastocyst, the primary germ layers and the germ cell lineage. Our recent findings indicate that human embryo development is characterized by a complex pattern of gene expression with the vast majority of genes that are modulated being down-regulated. Moreover, we observed that the majority of genes that are expressed in early human preimplantation development are of unknown function/identity. Thus, to probe function, we developed the tools necessary to examine one of the earliest decisions in human embryo development, namely the allocation of cells to the germ cell lineage. We have found that both human embryonic stem cells and human adult- and fetal-derived induced pluripotent stem cells can form both primordial germ cells and meiotic germ cells. Moreover, the use of hESCs and iPSCs allows the genetic dissection of human germ cell and somatic cell formation; we have found that a family of translational factors regulates germ cell formation, maintenance and differentiation.
Our understanding of the origins of common sporadic or idiopathic diseases in the human population is very limited. Often, genetically-defined etiologies represent a small subpopulation of affected individuals. Our long term goal is to combine modern technologies of human genetics and epigenetics, human embryology, stem cell biology and neurobiology, through a unique group of collaborators, in order to understand the etiology of sporadic PD. Our hypothesis is that we can distinguish sporadic PD that is genetically-based (hard-wired) from that which is epigenetic in origins (able to be erased), prior to transplantation of iPSC-derived neurons, based on recapitulation of cardinal features of PD in vitro following reprogramming. This hypothesis allows us to address a larger concept for long-term study and that is whether embryonic epigenetic errors that are observed at human imprinted loci are just a visible subset of a much larger set of errors that can present as common sporadic neurodegenerative disorders that arise later in life. We chose to focus on PD because of a unique set of observations that we believe makes PD ideal for inquiries into sporadic disease, in general, and neurodegenerative disease specifically.
Publications
- Dynamic blastomere behaviour reflects human embryo ploidy by the four-cell stage. Nat Commun. 2012: 1251
- LRRK2 mutant iPSC-Derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011: 114
- NANOS3 function in human germ cell development. Human Molecular Genetics (in press).. 2011
- Human germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells. Hum Mol Genet. 2010: 752-62
- Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage. Nat Biotechnol. 2010; (10): 1115-21
- Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. Nature. 2009; (7270): 222-5
Help